PI3K signalling: the path to discovery and understanding
By B. Vanhaesebroeck, L. Stephens, P. Hawkins. Nature reviews. Molecular cell biology, 2012
942 citations recorded by the source corpus.
Subfields: Molecular Biology
View Paper: https://www.semanticscholar.org/paper/522eb12d857619a61d2de5d77a45d43f4be4085b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
Citations in the corpus
- The ErbB/HER family of protein-tyrosine kinases and cancer. (2014, background): “Akt also catalyzes the phosphorylation and nhibition of Bcl2-associated death promoter (BAD); unphosphoylated BAD is pro-apoptotic [85].”
- PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma (2014, neutral): “Subtypes of indolent non-Hodgkin’s lymphoma included follicular lymphoma (72 patients), small lymphocytic lymphoma (28), marginal-zone lymphoma (15), and lymphoplasmacytic lymphoma with or without Waldenström’s macroglobulinemia (10).”
- A Homogeneous, High-Throughput Assay for Phosphatidylinositol 5-Phosphate 4-Kinase with a Novel, Rapid Substrate Preparation (2013, background): “Dysregulation of these pathways can lead to cancer and other diseases [1,2,3,4,5,6].”
- Phosphoinositides: tiny lipids with giant impact on cell regulation. (2013, background): “Several excellent reviews have summarized various aspects of this topic in greater details in recent years (75, 221, 467, 814, 996, 1609, 1612, 1613, 1640, 1727, 1785).”
- Exosomes in Cancer Development, Metastasis and Drug Resistance: A Comprehensive Review (2013, positive): “Primarily, PTEN works by keeping PI3K-AKT pathway (found constitutively activated in cancers) in check and regulates cell cycle progression [96].”
- Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways (2017, background): “Here, we will review the activation mechanisms by which the EGFR activates the ERK MAPK, AKT-PI3K, and PLC-γ1-PKC pathways, focusing on the molecular interactions between each protein in the pathways (Figure 1).”